Study of EOC317 in Chinese Patients With Advanced Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Solid Tumor
Interventions: DRUG: EOC317
Sponsor: Taizhou EOC Pharma Co., Ltd.